Moneycontrol
Get App
SENSEX NIFTY
you are here:

Laurus Labs Ltd.

BSE: 540222 | NSE: LAURUSLABS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE947Q01010 | SECTOR: Pharmaceuticals

BSE Live

Apr 03, 16:00
342.15 18.70 (5.78%)
Volume
AVERAGE VOLUME
5-Day
2,740
10-Day
3,790
30-Day
6,211
9,560
  • Prev. Close

    323.45

  • Open Price

    325.55

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Apr 03, 15:59
342.15 18.45 (5.70%)
Volume
AVERAGE VOLUME
5-Day
86,906
10-Day
80,101
30-Day
91,717
175,186
  • Prev. Close

    323.70

  • Open Price

    328.40

  • Bid Price (Qty.)

    342.15 (109)

  • Offer Price (Qty.)

    0.00 (0)

ANNOUNCEMENTS ON Laurus Labs

  • Apr 01, 2020 15:04 Source: BSE

    Laurus Labs - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 01, 2020 for Satyanarayana Chava

  • Mar 31, 2020 17:17 Source: BSE

    Laurus Labs - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 31, 2020 for Chunduru Venkata Lakshmana Rao

  • Mar 31, 2020 12:19 Source: BSE

    Laurus Labs - Closure of Trading Window

    Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended and the circular issued by the Stock Exchanges, the trading window for dealing in the shares of the Company shall remain closed from April 01, 2020 till 48 hours after the declaration of audited financial results for the quarter and year ended March 31, 2020. The date of Board Meeting of the Company for consideration and approval of the audited financial results for the quarter and year ended March 31, 2020 will be intimated later.

  • Mar 27, 2020 21:42 Source: BSE

    Laurus Labs - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    RISING PHARMACEUTICALS AND LAURUS LABS PARTNER TO SUPPORT THE UNIVERSITY OF MINNESOTA TO EXPLORE THE PROPHYLAXIS EFFECT OF HYDROXYCHLOROQUINE IN ESSENTIAL HEALTH CARE WORKERS

  • Mar 26, 2020 21:13 Source: BSE

    Laurus Labs - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    Dr. Satyanarayana Chava, Founder & CEO, Laurus labs, accompanied by Mr. Chandrakanth Chereddi, Executive Director, Mr. Krishna Chaitanya Chava, Executive Vice President, Corporate Development, Synthesis and Ingredients, Laurus Labs met Sri. Chandrasekhar Rao, Honorable Chief Minister of Telangana at his office and donated 1 lakh tablets of Hydroxychloroquine (HCQ) Tablets IP 200mg, as mitigation initiative and also donated a cheque of INR 50 Lakhs for other supporting suppression measures in the state of Telangana. In a similar way at Visakhapatnam, Andhra Pradesh, Mr. Narasimha Rao Chava, Vice President, Human Resources, Laurus Labs met V. Vinay Chand IAS, District Collector and Magistrate, and donated 1 lakh tablets of Hydroxychloroquine (HCQ) Tablets IP 200mg, as mitigation initiative and also donated a cheque of INR 50 Lakhs for other supporting suppression of the spread measures in the state of Andhra Pradesh.

  • Mar 26, 2020 17:17 Source: NSE

    Laurus Labs Limited

    Laurus Labs Limited has informed the Exchange about Payment of Interim Dividend for FY 2019-20

  • Mar 26, 2020 15:36 Source: BSE

    Laurus Labs - Announcement under Regulation 30 (LODR)-Date of payment of Dividend

    In furtherance to the corporate action dated March 12, 2020 regarding the payment of interim dividend, it is hereby informed that due to the current pandemic situation of COVID-19, the interim dividend will be paid on ''March 27, 2020'' itself, instead of earlier informed date of March 30, 2020. Further, the Dividend amount will be paid to the shareholders of the Company whose names appear in the register of members as on ''March 25, 2020'' the ''Record Date'' only as originally fixed for the purpose and there is no change in the Record Date.

  • Mar 21, 2020 13:32 Source: BSE

    Laurus Labs - Revsied Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

    The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 21, 2020 for Satyanarayana Chava

  • Mar 20, 2020 17:30 Source: BSE

    Laurus Labs - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 20, 2020 for Satyanarayana Chava

  • Mar 13, 2020 13:12 Source: BSE

    Laurus Labs - Fixes Record Date for Interim Dividend

    Laurus Labs Ltd has informed BSE that the Company has fixed March 25, 2020 as the Record Date for the purpose of Payment of Interim Dividend. The Dividend amount will be paid on or after March 30, 2020.

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Mar 12, 2020
Remark : Interim Dividend